THBS2 and glomerulosclerosis: Surprisingly, glomerulosclerosis (Fig. 3A; 4A–B) and tubulointerstitial injury (Fig. 3B, 4C–D) in the graft were more severe in the group treated with TSP-2 gene therapy compared to the control plasmid treated rats.